Support WBURFDA Expedites Treatment Of Seriously Ill COVID-19 Patients With Experimental PlasmaJoe PalcaMarch 24, 2020 ShareThe U.S. Food and Drug Administration announced that it will make it easier for an experimental plasma to be tried on patients with COVID-19. (AP)